Please login to the form below

Not currently logged in
Email:
Password:

Almirall appoints Peter Guenter as its CEO

He joins from Sanofi where he was executive vice president

Peter GuenterAlmirall has appointed Peter Guenter as its new chief executive officer, succeeding Eduardo Sanchiz who leaves to spend more time dedicated to other interests.

Guenter joins from Sanofi, where he has worked for the past 22 years, most recently as executive vice president diabetes and cardiovascular global business unit.

He said: “I am excited and eager to join Almirall as CEO. The company has a clearly defined strategy, putting the patients and customers at the centre of everything we do.

“Together with my team, I am convinced we will be able to fully unlock the value of Almirall.”

He previously held many senior positions at Sanofi, including vice president Eastern Europe and Northern Europe, vice president business management and support, general manager, Germany, and senior vice president, Europe.

Jorge Gallardo, chairman of the board, Almirall, said: “I am particularly satisfied that we have been able to attract Peter to Almirall.

“He is a truly global leader and brings a wealth of experience in US, Europe, and emerging markets. I am convinced he will bring what is needed to develop Almirall to the next level.”

Sanchiz will hand over the leadership of Almirall to Guenter during September.

30th August 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GEM Marketing Ltd

GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....

Latest intelligence

Digital
Tools for the digital world
The next step for the pharma industry...
How Can We Make Payer Communications Really Sing?
With so many different influences at play in access decisions, how can we make sure we tap into what’s really driving payer decision-making. How do we go beyond the stated...
Harnessing the power of core elements to optimise market access
This article by John Spoors and Anton Abrahams focuses on optimising market access – the RJW and Solaris Health teams operate across all major markets, where the principles set out...

Infographics